Psoriatic Arthritis News and Research

RSS

Like rheumatoid arthritis (RA), psoriatic arthritis is a chronic inflammatory disease of the joints and connective tissue. The disease causes joint pain and swelling that can lead to crippling along with inflamed and irritated scaly red patches of skin throughout the body. It is a progressive and debilitating disease and because there are no treatments specifically approved for psoriatic arthritis, doctors often use therapies approved for RA, including nonsteroidal anti-inflammatory drugs (NSAIDs) and disease modifying anti-rheumatic drugs (DMARDs). However, no DMARDs are currently approved for use in psoriatic arthritis. There are approximately 300,000 patients with psoriatic arthritis in the United States and the disease affects both men and women most commonly between the ages 30 and 50. Psoriatic arthritis patients are generally treated by rheumatologists and dermatologists.

Corrona Psoriasis Registry to present studies at AAD Virtual Meeting Experience

The Corrona® Psoriasis Registry, a joint collaboration between the National Psoriasis Foundation, NPF, and Corrona, LLC, the leading sponsor of registries in immune-mediated diseases, announces that studies from the registry will be presented at the American Academy of Dermatology Virtual Meeting Experience taking place June 12-14, 2020.

12 Jun 2020

Deployment of health care professionals can improve inflammatory-rheumatic disorders

Inflammatory-rheumatic disorders are a widespread ailment, affecting at least 1.5 million people in Germany alone.

10 Jun 2020

Study uncovers link between psoriasis and joint disease

A team led by Case Western Reserve University School of Medicine researchers has made two major discoveries involving psoriasis, a chronic and debilitating skin disease with no known cure.

8 Jun 2020

Trial results show efficacy of netakimab for treating moderate-to-severe plaque psoriasis

Netakimab is a humanized anti-interleukin 17A antibody approved for the treatment of moderate-to-severe plaque psoriasis.

5 Jun 2020

EULAR publishes updated recommendations for treating people with psoriatic arthritis

The European League Against Rheumatism, EULAR, has published updated recommendations on the treatment of people with psoriatic arthritis.

27 May 2020

Cancer risk in psoriatic patients

A new study published in February 2020 in the journal JAMA Dermatology reports that there is a 21% increased risk of cancer in patients with psoriasis, but not with psoriatic arthritis alone.

19 Feb 2020

Research project moves one step closer to personalized treatment of rheumatic diseases

When a patient is diagnosed with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis, prescribing the correct type of medicine is a case of trial and error.

29 Jan 2020

Holistic Approaches to Psoriasis Treatment

Holistic approaches to psoriasis treatment involves lifestyle advice about weight, smoking, alcohol, sleep, exercise, and other factors.

From J&J Innovative Medicine 22 Jan 2020

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, today announced a US$8.8M Series A financing round with leading international healthcare investors Canaan and Australia’s Medical Research Commercialization Fund managed by Brandon Capital.

9 Jan 2020

Age of psoriasis onset decides if the skin or joints act up first

People with psoriatic arthritis may initially present with either psoriasis or arthritis as the first symptom/sign of this illness. Now, a new study presented at the 2019 ACR/ARP Annual Meeting shows that the age at which psoriasis develops is a key predictor of which shows up first. Early-onset psoriasis is not strongly associated with arthritis while late-onset psoriasis is.

11 Nov 2019

Methotrexate reduces joint damage in hand osteoarthritis

A new study presented at the 2019 ACR/ARP meeting shows that methotrexate stopped further damage to the hand joints and even perhaps improved bone remodeling in patients with osteoarthritis (OA) of the hand, when they were assessed at 3 and 12 months.

11 Nov 2019

Methotrexate appears to facilitate bone remodeling in patients with osteoarthritis

According to new research findings presented at the 2019 ACR/ARP Annual Meeting, methotrexate did not demonstrate superior efficacy over placebo for pain relief and function evolution at three and 12 months in patients with erosive hand osteoarthritis.

11 Nov 2019

Psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis

In a new study presented at the 2019 ACR/ARP Annual Meeting, researchers found that the age of psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis.

11 Nov 2019

Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

A new study found that very few serious infections were seen in children born to mothers with chronic inflammatory diseases who used non-TNFi biologics or tofacitinib during pregnancy compared to children not exposed to these drugs and children exposed to TNFi biologics in utero.

10 Nov 2019

Additional medications needed to control the symptoms of juvenile idiopathic arthritis

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, there is a profound ongoing need for additional medications to control the signs and symptoms of juvenile idiopathic arthritis, despite the availability of several approved biologic disease-modifying antirheumatic drugs (biologics).

10 Nov 2019

Psoriatic Arthritis News and Research

Further Reading

Corrona Psoriasis Registry to present studies at AAD Virtual Meeting Experience

Deployment of health care professionals can improve inflammatory-rheumatic disorders

Study uncovers link between psoriasis and joint disease

Trial results show efficacy of netakimab for treating moderate-to-severe plaque psoriasis

EULAR publishes updated recommendations for treating people with psoriatic arthritis

Cancer risk in psoriatic patients

Research project moves one step closer to personalized treatment of rheumatic diseases

Holistic Approaches to Psoriasis Treatment

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Age of psoriasis onset decides if the skin or joints act up first

Methotrexate reduces joint damage in hand osteoarthritis

Methotrexate appears to facilitate bone remodeling in patients with osteoarthritis

Psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis

Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

Additional medications needed to control the symptoms of juvenile idiopathic arthritis

Study reveals safety, efficacy of live zoster vaccine for people taking TNF inhibitors

Healthiest gut bacteria with plant-based or Mediterranean diet

Diagnostic value of ultrasound in comparing different types of arthritis

Finding potential treatments for autoimmune diseases

ACR and Arthritis Foundation release two guidelines on juvenile idiopathic arthritis

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News